ESPR
Esperion Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website esperion.com
- Employees(FY) 199
- ISIN US29664W1053
Performance
+12.92%
1W
+23.56%
1M
-12.27%
3M
+112.61%
6M
-21.07%
YTD
+34.09%
1Y
Profile
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Investment Analysis Report: ESPR
Overview:
ESPR, a pharmaceutical company in the Health Technology sector, has shown significant fluctuations in its financial performance over the past three years. This report will delve into the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and ca...
Technical Analysis of ESPR 2024-05-10
Overview:
In analyzing the technical indicators for ESPR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
Recent News & Updates
- 2024-05-13 20:00
- 2024-05-10 04:00
- 2024-05-08 00:20
- 2024-05-07 23:08
- 2024-05-07 15:04
- 2024-05-07 00:20
- 2024-05-06 22:55
- 2024-05-06 20:55
- 2024-05-06 20:22
Why Is Esperion Therapeutics (ESPR) Stock Up 13% Today?(Investorplace)
- 2024-05-06 19:39
- 2024-05-06 19:36
Top Premarket Gainers(Yahoo Finance)
- 2024-05-06 19:15
- 2024-05-06 18:11
Esperion Therapeutics: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-06 18:00
Esperion Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-28 20:00
Esperion to Participate in Upcoming May Investor Conferences(Globenewswire)
- 2024-04-22 20:00
- 2024-04-20 22:39
11 Best Low Price Pharma Stocks To Invest In(Insidermonkey)
- 2024-04-07 14:45
- 2024-04-07 02:45
- 2024-04-01 08:00
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024(GlobeNewswire)
- 2024-03-31 20:00
Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024(Globenewswire)
- 2024-03-28 11:30
- 2024-03-27 23:30
- 2024-03-26 08:00
- 2024-03-25 20:00
- 2024-03-25 16:00
- 2024-03-25 04:00
- 2024-03-22 18:26
- 2024-03-22 15:10
- 2024-03-22 11:04
Page 1 of 6
previousnext